Clackamas, Oregon Clinical Trials

A listing of Clackamas, Oregon clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 54 clinical trials
Study Condition

Study Condition

Portland Site
 (7.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Effects of Pau d' Arco in Primary Dysmenorrhea

A single arm, open-label trial evaluating safety and tolerability of encapsulated Tabebuia avellanedae in 12 generally healthy women aged 18-45 with primary dysmenorrhea (PDM). This will be the first study evaluating the safety and tolerability of Tabebuia avellanedae in PDM. We also aim to collect proof-of-concept mechanistic data supporting the …

copper
paragard
fasting
dysmenorrhea
National University of Natural Medicine
 (8.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Effects of a Specific Substance in Smokers

Although rates of cigarette use are declining, the proportion of nondaily smokers is rising, particularly among young adults. Among young adults, nondaily smoking is associated with negative health consequences and, for some, may lead to the establishment of life-long smoking patterns. The goal of this project is to understand the …

Oregon Health and Science University
 (7.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Naproxen Pharmacogenetic Study (Project 1 Aim 2)

This is a mechanism-based study in healthy adults to determine the effect of the CYP2C9 M1L gene polymorphism on the functional activity of the encoded CYP2C9 enzyme towards the probe substrate naproxen. CYP2C9 activity will be evaluated by measurement of O-desmethyl naproxen and unchanged naproxen in 24-hour urine following administration …

Oregon Health & Science University
 (7.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

Opaganib, a sphingosine kinase-2 (SphK2) inhibitor, has been broadly tested in Phase I/II studies. Extensive nonclinical data indicates both anti-viral and anti-inflammatory activity via selective SphK2 inhibition which may prove beneficial for treating COVID-19 infection and resulting pneumonia. This proof of concept study will take place in the US and …

oropharyngeal
coronavirus infection
opaganib
chest x-ray
covid-19
Oregon Health & Science University
 (7.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

cancer therapy
endometrial cancer
paclitaxel
carboplatin
carboplatin paclitaxel
Research Site
 (7.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +94 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

aphasia
progranulin
dementia
pick's disease
Oregon Health and Science University
 (7.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +46 other locations
Study Details  

 

Portland Site
 (7.2 away)
  • 0 views
  • 16 Feb, 2024
  • 1 location
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

tricuspid valve replacement
medical therapy
Oregon Health & Science University
 (7.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma

This is a single-arm, open-label, multicenter, Phase 1 study evaluating the safety and efficacy of CTX120 in subjects with relapsed or refractory multiple myeloma.

refractory multiple myeloma
multiple myeloma
Research Site 3
 (7.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +5 other locations